gene_symbol
SLAMF7
hgnc_id
HGNC:21394
binding_type
antigen recognition
cytotoxicity
YES
cytotoxicity_type
DIRECT
cytotoxicity_mechanism
Elotuzumab binds SLAMF7 on target cells and its Fc engages Fcγ receptors on NK cells, triggering antibody‑dependent cellular cytotoxicity (ADCC) to kill SLAMF7‑positive cells.
enzyme_product
Off
epitope
Off
variant
Off
isoform
Off
hla_specific
Off
gated
Off
trial_id_tar_ref
drug_id_tar_ref
disease_id_tar_ref
nct_id_tar_ref
NCT06208150
disease_id_num_tar_ref
4559
drug_id_num_tar_ref
12313